DENND1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.343000E-01
Normal-vs-Stage2
5.230400E-01
Normal-vs-Stage3
2.057400E-01
Normal-vs-Stage4
7.066600E-01
Stage1-vs-Stage2
8.867000E-01
Stage1-vs-Stage3
3.437800E-01
Stage1-vs-Stage4
2.834000E-01
Stage2-vs-Stage3
3.012600E-01
Stage2-vs-Stage4
1.189400E-01
Stage3-vs-Stage4
1.545170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.179800E-01
Normal-vs-AfricanAmerican
8.615400E-01
Normal-vs-Asian
4.852600E-01
Caucasian-vs-AfricanAmerican
1.497440E-01
Caucasian-vs-Asian
8.759800E-01
AfricanAmerican-vs-Asian
2.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.394400E-01
Normal-vs-Female
3.686200E-01
Male-vs-Female
2.573600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.154200E-01
Normal-vs-Age(41-60Yrs)
7.675800E-01
Normal-vs-Age(61-80Yrs)
3.528600E-01
Normal-vs-Age(81-100Yrs)
9.030000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.512200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.878200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.535200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.654100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.003760E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.663800E-01
Normal-vs-Daily Drinker
1.599560E-01
Normal-vs-Weekly Drinker
5.330400E-01
Normal-vs-Occasional Drinker
7.248800E-01
Normal-vs-Social Drinker
4.995000E-01
Non Drinker-vs-Daily Drinker
1.736790E-01
Non Drinker-vs-Weekly Drinker
9.468800E-01
Non Drinker-vs-Occasional Drinker
4.399400E-01
Non Drinker-vs-Social Drinker
7.951800E-01
Daily Drinker-vs-Weekly Drinker
3.833000E-01
Daily Drinker-vs-Occasional Drinker
8.830000E-02
Daily Drinker-vs-Social Drinker
1.813950E-01
Weekly Drinker-vs-Occasional Drinker
5.642400E-01
Weekly Drinker-vs-Social Drinker
8.188400E-01
Occasional Drinker-vs-Social Drinker
6.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.330560E-01
Normal-vs-Grade 2
3.735700E-02
Normal-vs-Grade 3
3.518300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.088400E-02
Grade 1-vs-Grade 3
6.138300E-03
Grade 1-vs-Grade 4
1.330560E-01
Grade 2-vs-Grade 3
7.867900E-02
Grade 2-vs-Grade 4
3.735700E-02
Grade 3-vs-Grade 4
3.518300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.312200E-01
Normal-vs-NonDiabetic
3.077800E-01
Diabetic-vs-NonDiabetic
8.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.431200E-01
Normal-vs-NoPancreatitis
3.081200E-01
Pancreatitis-vs-NoPancreatitis
3.058600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.354200E-01
Normal-vs-N1
4.875000E-01
N0-vs-N1
5.374200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.341200E-01
Normal-vs-TP53-NonMutant
6.162400E-01
TP53-Mutant-vs-TP53-NonMutant
4.837700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
